Literature DB >> 30586718

Ryanodine Receptor Glycation Favors Mitochondrial Damage in the Senescent Heart.

Marisol Ruiz-Meana1,2, Marta Minguet1, Diana Bou-Teen1, Elisabet Miro-Casas1,2, Celia Castans3, Jose Castellano1, Elena Bonzon-Kulichenko3, Alberto Igual1, Rafael Rodriguez-Lecoq1, Jesús Vázquez2,3, David Garcia-Dorado1,2.   

Abstract

BACKGROUND: Senescent cardiomyocytes exhibit a mismatch between energy demand and supply that facilitates their transition toward failing cells. Altered calcium transfer from sarcoplasmic reticulum (SR) to mitochondria has been causally linked to the pathophysiology of aging and heart failure.
METHODS: Because advanced glycation-end products accumulate throughout life, we investigated whether intracellular glycation occurs in aged cardiomyocytes and its impact on SR and mitochondria.
RESULTS: Quantitative proteomics, Western blot and immunofluorescence demonstrated a significant increase in advanced glycation-end product-modified proteins in the myocardium of old mice (≥20months) compared with young ones (4-6months). Glyoxalase-1 activity (responsible for detoxification of dicarbonyl intermediates) and its cofactor glutathione were decreased in aged hearts. Immunolabeling and proximity ligation assay identified the ryanodine receptor (RyR2) in the SR as prominent target of glycation in aged mice, and the sites of glycation were characterized by quantitative mass spectrometry. RyR2 glycation was associated with more pronounced calcium leak, determined by confocal microscopy in cardiomyocytes and SR vesicles. Interfibrillar mitochondria-directly exposed to SR calcium release-from aged mice had increased calcium content compared with those from young ones. Higher levels of advanced glycation-end products and reduced glyoxalase-1 activity and glutathione were also present in atrial appendages from surgical patients ≥75 years as compared with the younger ones. Elderly patients also exhibited RyR2 hyperglycation and increased mitochondrial calcium content that was associated with reduced myocardial aerobic capacity (mitochondrial O2 consumption/g) attributable to less respiring mitochondria. In contracting HL-1 cardiomyocytes, pharmacological glyoxalase-1 inhibition recapitulated RyR2 glycation and defective SR-mitochondria calcium exchange of aging.
CONCLUSIONS: Mitochondria from aging hearts develop calcium overload secondary to SR calcium leak. Glycative damage of RyR2, favored by deficient dicarbonyl detoxification capacity, contributes to calcium leak and mitochondrial damage in the senescent myocardium.

Entities:  

Keywords:  aging; calcium; mitochondria; sarcoplasmic reticulum

Year:  2019        PMID: 30586718     DOI: 10.1161/CIRCULATIONAHA.118.035869

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Mapping protein carboxymethylation sites provides insights into their role in proteostasis and cell proliferation.

Authors:  Simone Di Sanzo; Katrin Spengler; Anja Leheis; Joanna M Kirkpatrick; Theresa L Rändler; Tim Baldensperger; Therese Dau; Christian Henning; Luca Parca; Christian Marx; Zhao-Qi Wang; Marcus A Glomb; Alessandro Ori; Regine Heller
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

2.  MCU overexpression evokes disparate dose-dependent effects on mito-ROS and spontaneous Ca2+ release in hypertrophic rat cardiomyocytes.

Authors:  Shanna Hamilton; Radmila Terentyeva; Fruzsina Perger; Benjamín Hernández Orengo; Benjamin Martin; Matthew W Gorr; Andriy E Belevych; Richard T Clements; Sandor Györke; Dmitry Terentyev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 5.125

3.  Microgravity-induced stress mechanisms in human stem cell-derived cardiomyocytes.

Authors:  Aviseka Acharya; Harshal Nemade; Symeon Papadopoulos; Jürgen Hescheler; Felix Neumaier; Toni Schneider; Krishna Rajendra Prasad; Khadija Khan; Ruth Hemmersbach; Eduardo Gade Gusmao; Athanasia Mizi; Argyris Papantonis; Agapios Sachinidis
Journal:  iScience       Date:  2022-06-11

Review 4.  Structure-function relationships and modifications of cardiac sarcoplasmic reticulum Ca2+-transport.

Authors:  M Nusier; A K Shah; N S Dhalla
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

5.  Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases.

Authors:  Mohit M Hulsurkar; Satadru K Lahiri; Jason Karch; Meng C Wang; Xander H T Wehrens
Journal:  Expert Opin Ther Targets       Date:  2022-04-25       Impact factor: 6.797

Review 6.  Ageing, sex, and cardioprotection.

Authors:  Marisol Ruiz-Meana; Kerstin Boengler; David Garcia-Dorado; Derek J Hausenloy; Tuuli Kaambre; Georgios Kararigas; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 7.  Sarcoplasmic reticulum-mitochondria communication; implications for cardiac arrhythmia.

Authors:  Shanna Hamilton; Radmila Terentyeva; Richard T Clements; Andriy E Belevych; Dmitry Terentyev
Journal:  J Mol Cell Cardiol       Date:  2021-04-17       Impact factor: 5.000

8.  Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy.

Authors:  Jessica Gambardella; Stanislovas S Jankauskas; Salvatore Luca D'Ascia; Celestino Sardu; Alessandro Matarese; Fabio Minicucci; Pasquale Mone; Gaetano Santulli
Journal:  J Heart Lung Transplant       Date:  2021-12-26       Impact factor: 10.247

9.  Cisd2 is essential to delaying cardiac aging and to maintaining heart functions.

Authors:  Chi-Hsiao Yeh; Zhao-Qing Shen; Shao-Yu Hsiung; Pei-Chun Wu; Yuan-Chi Teng; Yi-Ju Chou; Su-Wen Fang; Chian-Feng Chen; Yu-Ting Yan; Lung-Sen Kao; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  PLoS Biol       Date:  2019-10-08       Impact factor: 8.029

Review 10.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.